Brief: Acrux Says Mutually Terminated License Agreement With Harris
Oct 11 (Reuters) - Acrux Ltd ACR.AX :
* CO AND HARRIS HAVE MUTUALLY TERMINATED LICENSE AGREEMENT
FOR
PRILOCAINE 2.5% AND LIDOCAINE 2.5% CREAM
* CURRENTLY NEGOTIATING A LICENSING DEAL WITH ANOTHER
SPECIALIST
GENERIC CO IN U.S.
Source text for Eikon: ID:nASX3vjGl2
Further company coverage: ACR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acrux
See all newsBrief: Acrux Licenses Lenzetto For Australian Market For A$5.4 Million
Brief: Hungary's Richter and Acrux agree to license transdermal Estradiol spray for Australia
Brief: Acrux Says Capital Gains Tax Exemptions Remain In Place For Acrux
Australia's Acrux jumps on placement to fund female testosterone program
Brief: Acrux Raises A$1.6 Mln Via At 0.95 AU Cents Per Share